- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Gastric Carcinoma in Japan
Total 1104 results
-
Showa Inan General HospitalWithdrawnGastro-oesophageal RefluxJapan
-
AstraZenecaTerminatedGastric Cancer | Gastro-oesophageal Junction CancerBulgaria, Czech Republic, Italy, Korea, Republic of, Spain, United Kingdom, Hungary, Romania, Ukraine, Belgium, Canada, Germany, Taiwan, India, Japan, France
-
Astellas Pharma Global Development, Inc.RecruitingPancreatic Adenocarcinoma | Gastric Adenocarcinoma | Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Japan, Korea, Republic of, France
-
Fukushima Medical University HospitalUnknown
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
AstraZenecaCompleted
-
GlaxoSmithKlineCompletedCarcinoma, Renal CellJapan
-
Eli Lilly and CompanyCompleted
-
Tokyo UniversityShionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima... and other collaboratorsUnknownNon-small- Cell Lung CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownNon Small Cell Lung CancerJapan
-
Hamamatsu UniversityCompletedNon-Small Cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.TerminatedNon-small-cell Lung CancerJapan
-
Eli Lilly and CompanyCompletedLymphoma | Carcinoma, Non-Small-Cell Lung | Solid TumorsJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownNon Small Cell Lung CancerJapan
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
Kyoto UniversityCompleted
-
BayerActive, not recruiting
-
NanobiotixRecruitingAged | Locally Advanced Head and Neck Squamous Cell CarcinomaFrance, Spain, Israel, United States, Taiwan, Finland, Japan, Belgium, Korea, Republic of, Hungary, China, Georgia, Portugal, Austria, Bulgaria, Canada, Czechia, Germany, Greece, Romania, Serbia
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.RecruitingAdvanced Solid TumorsKorea, Republic of, China, Japan
-
BayerCompletedCarcinoma, Renal CellJapan
-
Wakayama Medical UniversityMerck Sharp & Dohme LLCUnknownSmall Cell Lung Cancer Extensive StageJapan
-
Kansai Hepatobiliary Oncology GroupCompletedIntrahepatic CholangiocarcinomaJapan
-
TakedaRecruitingNon-small Cell Lung Cancer (NSCLC)Japan
-
Bristol-Myers SquibbOno Pharma USA IncCompletedKidney Cancer | Renal CancerJapan
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCRecruitingAdvanced Solid TumorsUnited States, Japan
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerUnited States, France, Germany, Korea, Republic of, Taiwan, United Kingdom, Spain, Italy, Japan, Australia
-
Osaka UniversityOno Pharmaceutical Co. Ltd; Kyowa Kirin Co., Ltd.; Clinical Study Support, Inc.; Fiverings Co., Ltd...CompletedGastric Cancer | Esophageal Cancer | Lung Cancer | Renal Cancer | Oral CancerJapan
-
Shiga UniversityTokyo UniversityCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityTokyo UniversityCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon-Small Cell Lung CancerJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedSmall Cell Lung CancerJapan
-
Merck KGaA, Darmstadt, GermanyCompletedSquamous Cell Carcinoma of the Head and NeckJapan
-
Taiho Oncology, Inc.RecruitingAdvanced Cholangiocarcinoma | FGFR2 Fusions | Gene RearrangementUnited States, Korea, Republic of, Spain, Japan, Portugal, Italy, China, Argentina, Brazil, Poland, Australia
-
Kindai UniversityCompletedHepatocellular CarcinomaJapan
-
City of Hope Medical CenterRecruitingHepatocellular Carcinoma | Primary Liver Cancer | Cholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Hepatic Cancer | Hepatic Carcinoma | Primary Liver CarcinomaUnited States, Japan
-
Tokyo Women's Medical UniversityCompletedKidney Cancer | Metastatic CancerJapan
-
PfizerCompletedCarcinoma, Non-Small-Cell LungJapan
-
Kyowa Kirin Co., Ltd.CompletedPrimary Hyperparathyroidism | Parathyroid CarcinomaJapan
-
Kyowa Kirin Co., Ltd.CompletedPrimary Hyperparathyroidism | Parathyroid Carcinoma | HypercalcemiaJapan
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerJapan
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedRecurrent Hepatocellular Carcinoma | Child-Pugh Class A | Child-Pugh Class BUnited States, Japan
-
Shiga UniversityCompletedNon-small Cell Lung CancerJapan
-
Eli Lilly and CompanyCompletedColorectal CarcinomaJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon-small Cell Lung CancerJapan
-
Tokyo Medical and Dental UniversityWithdrawnHepatocellular Carcinoma | Cholangiocarcinoma | Gallbladder Neoplasms | HepatomaJapan
-
AstraZenecaCompletedAdvanced Solid Malignancies | Malignant LymphomaUnited Kingdom, Japan
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of, China, Japan
-
Novartis PharmaceuticalsCompletedStomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 ProteinTaiwan, Switzerland, Korea, Republic of, Germany, United States, Japan